General Information of the Compound
Compound ID
CP0534881
Compound Name
6-bromo-2-[(2-fluorophenyl)methyl]-3,4-dihydropyrazino[1,2-a]benzimidazol-1-one
    Show/Hide
Structure
Formula
C17H13BrFN3O
Molecular Weight
374.213
Canonical SMILES
Fc1ccccc1CN1CCn2c(nc3cccc(Br)c23)C1=O
    Show/Hide
InChI
InChI=1S/C17H13BrFN3O/c18-12-5-3-7-14-15(12)22-9-8-21(17(23)16(22)20-14)10-11-4-1-2-6-13(11)19/h1-7H,8-10H2
    Show/Hide
InChIKey
VZJZANASSVMWGG-UHFFFAOYSA-N
Physicochemical Property
logP
3.5939
Rotatable Bonds
2
Heavy Atom Count
23
Polar Areas
38.13
Hydrogen Bond Donor Count
0
Hydrogen Bond Acceptor Count
3
Complexity
23

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 166635427
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01748, Metabotropic glutamate receptor 2
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000064 Chem-1 Rattus norvegicus (Rat)  1
1
EC50 = 250 nM
   TI
   LI
   LO
   TS